These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1315 related articles for article (PubMed ID: 24555561)

  • 21. In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure.
    Augostini P; Bradley ELP; Raphael BH; Secor WE
    Sex Transm Dis; 2023 Jun; 50(6):370-373. PubMed ID: 36849257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of trichomoniasis with tinidazole following desensitization in a patient allergic to metronidazole.
    Biagi M; Slipke W; Smalley A; Tsaras G
    Int J STD AIDS; 2021 Jan; 32(1):89-91. PubMed ID: 33121364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cure of metronidazole- and tinidazole-resistant trichomoniasis with use of high-dose oral and intravaginal tinidazole.
    Saurina G; DeMeo L; McCormack WM
    Clin Infect Dis; 1998 May; 26(5):1238-9. PubMed ID: 9597267
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic aspects of trichomoniasis].
    Vukićević J; Jankicević J
    Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late recurrence of resistant Trichomonas vaginalis vaginitis: relapse or re-infection?
    Kanno M; Sobel JD
    Sex Transm Infect; 2003 Jun; 79(3):260-1. PubMed ID: 12794219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
    Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
    J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trichomoniasis in teens: an update.
    Huppert JS
    Curr Opin Obstet Gynecol; 2009 Oct; 21(5):371-8. PubMed ID: 19491679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
    Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
    Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trichomonas vaginalis Infection in a Tertiary Care Vaginitis Center.
    Keating MA; Nyirjesy P
    Sex Transm Dis; 2015 Sep; 42(9):482-5. PubMed ID: 26267873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates.
    Snipes LJ; Gamard PM; Narcisi EM; Beard CB; Lehmann T; Secor WE
    J Clin Microbiol; 2000 Aug; 38(8):3004-9. PubMed ID: 10921968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of amixicile against T. vaginalis from clinical isolates.
    Jain E; Zaenker EI; Hoffman PS; Warren CA
    Parasitol Res; 2022 Aug; 121(8):2453-2455. PubMed ID: 35676563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of refractory Trichomonas vaginalis infection using intravenous metronidazole.
    Hawkins I; Carne C; Sonnex C; Carmichael A
    Int J STD AIDS; 2015 Aug; 26(9):676-8. PubMed ID: 25161176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous metronidazole, liquid tinidazole, and intra-vaginal boric acid to cure trichomonas in a patient with gastric bypass surgery.
    Butt S; Tirmizi A
    Int J STD AIDS; 2018 Jul; 29(8):825-827. PubMed ID: 29393008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis.
    Walker PP; Hall RE; Wilson JD
    Int J STD AIDS; 1997 Jul; 8(7):473. PubMed ID: 9228600
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
    Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014.
    Sherrard J; Ison C; Moody J; Wainwright E; Wilson J; Sullivan A
    Int J STD AIDS; 2014 Jul; 25(8):541-9. PubMed ID: 24616117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.